Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN.
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis research"
DOI: 10.1016/j.thromres.2020.04.007
Abstract: BACKGROUND Direct oral anticoagulants (DOAC) and vitamin K antagonists (VKA) prevent thromboembolism in atrial fibrillation (AF). DOAC have a fixed dosing regimen and obviate INR monitoring. Therefore, DOAC presumably affect quality of life (QoL) less… read more here.
Keywords: doac; well controlled; switching well; direct oral ... See more keywords